h.espinoza

TL2 · Monterrey

Contributes reviews on supplier material. Based in Monterrey.

Joined 11 December 2024 · last posted 19h

80 posts, newest first. Showing up to 150.

Comparing documentation quality across the directory, tabulated Replied, post #12 · Sourcing › Vendor reports · 27 Jul 2026 · 0 likes On post #10 — agreed on the reasoning, with one qualification. Summarising the comparing documentation quality thread so far, since it is long and the answer is buried:…
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #38 · Clinical › Bloodwork · 25 Jul 2026 · 6 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Asking a follow-up: new topic or new reply? Replied, post #71 · Start Here › How to Ask · 25 Jul 2026 · 0 likes Worth separating asking a follow-up as a question about the compound from asking a follow-up as a question about the documentation. They get answered by different…
Why the Start Here categories exist, and what they are not for Replied, post #26 · Start Here › Welcome · 22 Jul 2026 · 11 likes What I can speak to on Start is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #53 · Practice › Interactions · 22 Jul 2026 · 2 likes Delayed gastric emptying and oral was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Follow-up: Prior authorisation: what the criteria usually require Replied, post #62 · Access › Insurance & coverage · 8 Jul 2026 · 0 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. I have kept the units in…
I joined for one answer and stayed for a year — what changed my mind Replied, post #49 · Start Here › Welcome · 29 Jun 2026 · 18 likes You do not need to introduce yourself before asking a question, and nobody will think worse of you for arriving with one. The introductions subcategory exists for…
Batch numbers that do not match the vial label Replied, post #35 · Sourcing › Red flags · 27 Jun 2026 · 24 likes A supplier changing batch nomenclature is not a warning sign, and it does make historical comparison harder until a mapping exists.
A plateau that disappeared when I changed how I measured — the long version Replied, post #55 · Outcomes › Progress reports · 26 Jun 2026 · 1 like Adding the measurement that post #52 says would settle it. The honest answer on plateau is that it depends, and the useful part is the list of what it depends on. Four…
Revisiting: What pooling buys you and what it destroys Replied, post #68 · Evidence › Meta-analyses · 26 Jun 2026 · 12 likes Everything in post #66 holds. The case it does not cover is the one I have. A note on how pooling buys gets discussed rather than on pooling buys itself: the confident…
Spreadsheets: an appreciation — what changed since Replied, post #69 · Lounge › Off topic · 13 Jun 2026 · 20 likes Mildly off-topic appreciation: whoever maintains the storage-conditions document has kept it current through three revisions without ever overstating what the…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #66 · Practice › Storage & stability · 6 Jun 2026 · 26 likes I had written a reply contradicting post #64 and deleted it. Here is what survived. Reconstituted material carried in a bag for a day is a temperature excursion even in…
An appeal that succeeded, with the letter structure — the long version Replied, post #21 · Access › Insurance & coverage · 27 May 2026 · 1 like Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #10 · Compounds › Secretagogues & GH axis · 25 May 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Second pass at: A pooled estimate that changed when one trial was added Replied, post #7 · Evidence › Meta-analyses · 17 May 2026 · 2 likes Pooled estimate is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which…
A calculator that gives a right answer to the wrong question Replied, post #21 · Data & Tools › Calculators · 14 May 2026 · 1 like Seconded. It reads as careful rather than confident, which is the right register.
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #103 · Practice › Interactions · 10 May 2026 · 0 likes Post #101 and I disagree about the size of the effect, not about the direction. Supplements and herbs: many have no established interaction. Some do. If you are taking…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #49 · Compounds › Repair & healing peptides · 6 May 2026 · 5 likes Confirming post #47 from a second method, which matters more than confirming it from a second person. The lyophilised cake is worth looking at before adding diluent. A…
Why the titration planner refuses to produce a schedule below a floor Replied, post #66 · Data & Tools › Calculators · 26 Apr 2026 · 0 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
Prediction intervals and why they are more honest than confidence intervals Replied, post #26 · Evidence › Meta-analyses · 11 Apr 2026 · 0 likes I keep a log for prediction intervals specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
Follow-up: State-level differences that actually matter Replied, post #79 · Regional › North America · 8 Apr 2026 · 0 likes A note on scope: what I am saying about State-level differences applies to the case in the first post and I would not extend it further without checking.
Journal club: is percentage weight change the right endpoint? Replied, post #10 · Evidence › Journal club · 23 Mar 2026 · 7 likes This follows post #9 rather than contradicting it. The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that…
Designing a personal experiment that could change your mind — one year on Replied, post #21 · Research Methods › N-of-1 designs · 15 Mar 2026 · 0 likes Reporting the whole series rather than the interesting segment is the discipline that makes personal data worth reading. Selective reporting is the default without…
Second pass at: The topic list is dense — is that deliberate? Replied, post #97 · Meta › Site feedback · 12 Mar 2026 · 21 likes A request rather than an answer: could whoever has the primary source for topic list post it? I have seen the claim three times this month and each version had lost a…
Peer-to-peer review: what actually happens on the call — one year on Replied, post #3 · Access › Insurance & coverage · 27 Feb 2026 · 23 likes Where I part company with the opening post, and it is a narrow parting. Reimbursement changes: a compound covered one year might not be the next. A formulary decision…
Reconstitution volumes that produce round numbers, tabulated Replied, post #46 · Practice › Reconstitution · 15 Feb 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
Mass error in ppm: the arithmetic and the caveat Replied, post #59 · Analytics › Mass spectrometry · 14 Feb 2026 · 1 like Seconded. It reads as careful rather than confident, which is the right register.
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #4 · Clinical › Bloodwork · 13 Feb 2026 · 1 like I had read the opposite somewhere and cannot now find where, which tells me something.
Lipase elevation without symptoms: the interpretation problem Replied, post #22 · Clinical › Bloodwork · 3 Feb 2026 · 8 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. A…
Run-in periods and the population they select Replied, post #58 · Evidence › Trials · 30 Jan 2026 · 0 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. Run-in periods has been discussed here with more heat than it deserves, mostly…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #3 · Outcomes › Progress reports · 25 Jan 2026 · 4 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
Pharmacy supply in the UK and the questions you will be asked Replied, post #18 · Regional › UK & Ireland · 23 Jan 2026 · 0 likes The arithmetic in post #15 is right; the assumption feeding it is the part to check. What I would check first on pharmacy supply is whether the thing being measured…
A partial dose because the pen emptied mid-injection Replied, post #83 · Practice › Administration · 10 Jan 2026 · 0 likes The number people quote for partial dose because the pen is a central estimate presented without its interval, and the interval is wide enough that the estimate is…
A partial dose because the pen emptied mid-injection Replied, post #62 · Practice › Administration · 9 Jan 2026 · 20 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #31 · Devices › Pens & autoinjectors · 18 Dec 2025 · 2 likes Air in a cartridge behaves differently from air in a syringe because the mechanism displaces a fixed volume regardless. That is what priming addresses. Posted with less…
The decimal-point error, and the habit that catches it Replied, post #61 · Practice › Reconstitution · 16 Dec 2025 · 18 likes On post #57 — agreed on the reasoning, with one qualification. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It…
Dead volume across syringe and needle combinations Replied, post #34 · Devices › Syringes & needles · 6 Dec 2025 · 0 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful.
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #48 · Analytics › Impurities & related substances · 24 Nov 2025 · 22 likes Post #46 and I disagree about the size of the effect, not about the direction. Comparing impurity profiles across suppliers is much more informative than comparing…
Temperature loggers worth the money — the long version Replied, post #66 · Devices › Cold chain · 31 Oct 2025 · 0 likes Everything in post #62 holds. The case it does not cover is the one I have. A parcel sitting in a vehicle or a depot in a hot month is the excursion that matters and…
New subcategory: rationale and scope Replied, post #66 · Meta › Announcements · 20 Oct 2025 · 1 like This is the answer, and the reason it is the answer is the more useful part.
A preprint whose numbers changed substantially at publication Replied, post #88 · Evidence › Preprints · 12 Oct 2025 · 23 likes Bookmarking this. I will come back when I have something worth adding.
Compounds this community declines to help with, and why Replied, post #68 · Compounds › Other compounds · 5 Oct 2025 · 11 likes Adding the measurement that post #67 says would settle it. This subcategory exists because some people will research compounds outside the main groups discussed here.…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #6 · Practice › Storage & stability · 28 Sep 2025 · 3 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. Reporting rather than recommending, on Storing lyophilised material long term. What…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #13 · Evidence › Preprints · 26 Sep 2025 · 14 likes Fair, and the limits you put on it are the part I will remember.
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #44 · Analytics › HPLC & UHPLC · 7 Sep 2025 · 0 likes Post #40 and I disagree about the size of the effect, not about the direction. Detection wavelength looks different depending on whether you are reading the primary…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #9 · Evidence › Journal club · 9 Aug 2025 · 10 likes Small correction to my own earlier position on orforglipron phase 2. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #21 · Compounds › Tirzepatide · 1 Aug 2025 · 0 likes Two questions I would want answered before drawing anything from the GIP component of tirzepatide data above: how were the cases selected, and what happened to the ones…
Checking someone else's arithmetic: a worked example thread Replied, post #63 · Practice › Reconstitution · 2 Jul 2025 · 30 likes I read post #62 twice before replying, because I had assumed the opposite. Preservative effectiveness is tested against a defined microbial challenge under defined…
Coming back to: When "no data" is the complete and final answer Replied, post #24 · Compounds › Other compounds · 25 Jun 2025 · 14 likes Narrowing post #22, because the general version has more than one answer. For any compound without a widely available reference standard, retention-time comparisons…
A report I filed that turned out to be wrong, and the correction Replied, post #115 · Sourcing › Vendor reports · 21 Jun 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 0 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
Sequence verification for an obscure compound: how it is done Replied, post #54 · Compounds › Other compounds · 5 Jun 2025 · 0 likes No notes. Posting so the count is not one.
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #2 · Sourcing › Vendor reports · 13 May 2025 · 24 likes Coming back to the opening post, because the follow-up matters more than the original answer. Since vendor documentation pages keeps coming up, it should probably be a…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #20 · Evidence › Journal club · 17 Apr 2025 · 13 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Reading it…
Storing a pen in use versus a pen unopened Replied, post #7 · Devices › Pens & autoinjectors · 10 Apr 2025 · 4 likes Post #5 and I disagree about the size of the effect, not about the direction. Pen confusion between compounds: if you are using multiple pens or alternating pens,…
When to suspect the method rather than the sample Replied, post #111 · Analytics › Method validation · 8 Apr 2025 · 14 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
Review: a draft on reconstitution arithmetic, with objections Replied, post #78 · Documentation › Doc review · 28 Mar 2025 · 29 likes Second this, and I would have said it less carefully.
Why cagrilintide alone is discussed so much less than in combination Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 24 Mar 2025 · 0 likes Post #17 describes the usual case. This is about the unusual one. The most useful reply I ever got about cagrilintide alone was a request to state my units. It sounds…
Adjudicated events and why the definition matters — the long version Replied, post #61 · Evidence › Trials · 23 Mar 2025 · 0 likes The figure that circulates in coverage is almost always whichever estimand gives the larger effect. That is not fraud; it is selection, and it is why the paper matters…
Coverage for the indication versus for the drug — a second dataset Replied, post #34 · Access › Insurance & coverage · 22 Mar 2025 · 19 likes Before the thread moves on from Coverage — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #123 · Pharmacology › Receptor biology · 18 Mar 2025 · 5 likes Worth separating two things that post #119 runs together. Biased agonism is a good example of a question where the honest answer is boring and the interesting answers…
Revisiting: German, French and Dutch differences, compared Replied, post #4 · Regional › European Union · 17 Mar 2025 · 21 likes Everything in post #2 holds. The case it does not cover is the one I have. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #36 · Analytics › Mass spectrometry · 16 Mar 2025 · 26 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #105 · Compounds › Other compounds · 4 Mar 2025 · 0 likes Adding a reference point for Research-use-only status. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #95 · Compounds › Other compounds · 20 Feb 2025 · 5 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #132 · Evidence › Journal club · 18 Feb 2025 · 2 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. That is the shape of it. The detail is where I would…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #82 · Sourcing › Regulatory · 10 Feb 2025 · 0 likes Post #78 put the caveat in the right place and I want to underline it. Research-use-only status is a legal classification, not a safety classification. It means the…
Triple agonism: additive, synergistic, or neither? Replied, post #15 · Compounds › Retatrutide · 2 Feb 2025 · 2 likes Narrowing post #12, because the general version has more than one answer. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it…
Why quantitation is the hard part, not detection Replied, post #3 · Analytics › Home & field testing · 30 Dec 2024 · 31 likes Source for the quantitation figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
[2026 update] New subcategory: rationale and scope Replied, post #91 · Meta › Announcements · 24 Dec 2024 · 25 likes The confident answers on New subcategory and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Training through a dose escalation week Replied, post #4 · Nutrition & Training › Resistance training · 19 Nov 2024 · 25 likes Where somebody is losing strength rapidly, the first questions are intake, sleep and total training volume, in that order. Written in the hope of being told what I have…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #36 · Compounds › Repair & healing peptides · 12 Nov 2024 · 12 likes Nobody has said the unglamorous part of reading a preclinical wound-healing model yet, so: most of the variation is explained by things that are boring to write about…
People with a low starting BMI: where the evidence stops Replied, post #13 · Clinical › Special populations · 6 Nov 2024 · 16 likes Athletes and people in substantial training loads are effectively unstudied, and the questions asked here about performance have no trial evidence behind them at all.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #7 · marked as the solution · Compounds › Tirzepatide · 23 Oct 2024 · 7 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #83 · Practice › Dosing & titration · 14 Oct 2024 · 23 likes There is no published evidence about slower escalation because nobody studied it. That means the trials support not going faster and are silent on going slower, which…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #20 · Practice › Side effects · 14 Oct 2024 · 1 like The arithmetic in post #17 is right; the assumption feeding it is the part to check. The question underneath nausea timeline is usually "how would I tell?" rather than…
Requesting a page: what makes a good request — what changed since Replied, post #49 · Documentation › Wiki requests · 10 Oct 2024 · 30 likes The arithmetic in post #48 is right; the assumption feeding it is the part to check. Link the topics that prompted the request. The discussion is the evidence that the…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #62 · Practice › Dosing & titration · 12 Sep 2024 · 4 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. I…
SURPASS-2 and the comparator dose question that will not go away Replied, post #7 · Compounds › Tirzepatide · 29 Aug 2024 · 12 likes Where the SURPASS-2 reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #2 · Practice › Interactions · 17 Aug 2024 · 0 likes Small methodological point on Grapefruit: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.